Optimize deals

Uncover and deliver on opportunities that build lasting value

Navigating deals in the pharmaceutical and life sciences industry requires confident decision making to stay a step ahead of competitive forces and ever-changing market dynamics. For those organizations that manage through the complexity inherent in deal making, the opportunities for value creation are compelling.

How PwC can help

PwC leverages our global outside-in perspective to help pharmaceutical and life science companies align strategy and capabilities to see and capture opportunities that work. We adapt to your company culture and share your commitment to long-term performance, continually evaluating the changing landscape to foresee opportunities.

Our teams provide advanced capabilities in valuation, deal structuring, implementation, and post-deal integration. Our services include:

  • Market entry evaluation
  • Organic/inorganic growth options
  • Valuation
  • Financial due diligence and capital markets support
  • Bid preparation
  • Commercial, tax, IT and operations due diligence
  • Carve out and separation analysis
  • Day one readiness
  • Infrastructure synergies
  • Risk and regulatory assessment
  • Integration for value capture
  • Dispute resolution
  • Tax structuring
  • People and change

More information on our US Deals practice.


Contact us

Glenn Hunzinger

Pharmaceutical and Life Sciences Deals Leader, PwC US

Follow us